People news

Share this article:
Aegerion Pharmaceuticals, a specialty manufacturer focused on cardiovascular and metabolic disease, has appointed Peter Garrambone, Jr., to the company's board of directors. Garrambone was previously a SVP, corporate strategic planning, at Pfizer.
 
SK&A, a marketing research firm, has promoted David Escalante, Jr., to president and CEO. Escalante was previously president and COO.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in People Moves

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in People Moves

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media